Background The magnitude of the relative risk of venous thrombosis caused by low-dose
oral contraceptive use is still debated because previous studies might have been affected by …

Objective A systematic review of studies published between January 1995 and April 2010
aimed at determining the effect of combined hormonal contraceptives (CHCs), administered …

Many drugs besides lipid-lowering drugs affect serum lipid levels in either a potentially
harmful or beneficial way, and may therefore increase or decrease the risk of cardiovascular …

The effect of oral contraceptives (OC) on fibrinolytic parameters was investigated in a cycle-
controlled cross-over study in which 28 non-OC using women were randomly prescribed …

Background. New studies about the influence of hormonal contraception on the risk of
venous thromboembolism (VTE) have been published. Aim. To evaluate new …

Activated protein C (APC) resistance, determined with a thrombin‐generation‐based APC
resistance test, may explain risk differences of venous thrombosis in users of second‐and …

The incidence of venous thrombosis is 1–3 individuals per 1000 per year, with a high rate of
complications and death. Men and women are affected about equally by venous thrombosis …

Objective To identify publication and citation trends, most productive institutions and
countries, top journals, most cited articles and authorship networks from articles that used …

Postcoital contraceptive pills (PCP) have recently been approved for use as emergency
contraception in the United States. The objective of this study was to assess the risk of …

Thrombophilia is the term now used to describe predisposition to increased risk of venous
and occasionally arterial thromboembolism due to hematological abnormalities. It can be a …